The LifeX Network Connecting People, Expertise, and Opportunities to Move Life Science Innovation Forward
The LifeX Model is Powered by Our People
LifeX was built on the belief that the right network, activated at the right moment, is the most valuable resource we can provide to life science startups.
Our goal within the ecosystem is to build and steward the infrastructure that leverages a broad network of individuals and organizations passionate about supporting life science startups.
From seasoned industry experts to operational leaders and interns, the people within our Network are the true force multiplier for innovation.
Seasoned Industry Experts
Operational Leaders
Interns
Experts Deployed
Mentors, Guest Experts, Embedded Entrepreneurs
Interns Hosted to Date
Students working in startups through LifeX programs
Network Events Hosted Annually
Connecting Founders, Experts, Investors & Ecosystem Partners
Network Participants
Founders, Researchers, Students. Industry Experts, Ecosystem Partners
The LifeX Network at a Glance
A Custom Network Built Around Your Startup’s Unique Needs 350+ Industry Experts When You Need Them
Join the LifeX Network
Mentor founders, support commercialization projects, and contribute to startup programming
Join a startup as an Embedded Entrepreneur and help lead commercialization efforts
Students/Young Professionals gain hands-on experience supporting startups and build your entrepreneurial tool-kit
Provide specialized services and resources to emerging life science companies
The LifeX Network in Action
LifeX Launchpad Case Study: Expora Therapeutics
LifeX had been developing a new program, LifeX Launchpad, designed to provide the kind of sustained, execution-focused support that accelerators typically cannot. The team needed the right company to pilot it with, and in Nick they saw a founder worth investing in: deeply knowledgeable, eager to learn, and willing to do the work. The potential in both the technology and the founder behind it made Expora a natural fit.
LifeX’s primary contribution was in how it designed the engagement: identifying the right experts, aligning them around Expora’s most critical gaps, and creating the structure for a working team rather than a roster of advisors. Rather than assigning a single mentor or offering office hours, LifeX assembled a dedicated, multidisciplinary group and embedded them into the company’s work on a weekly cadence alongside Ron J’ support : enter Sam Rothstein, Susan Catalano, and Mark Collins.
Result:
Expora evolved from a university spinout into an investable company leveraging platform technology for industry partnerships, coupled with a therapeutic candidate with an ideal target product profile in a high value disease.
LifeX Connect Case Study: Netramind Innovations
Netramind’s transition from academic research to a venture-backable company began with early engagement in LifeX programming, where investor and operator feedback clarified the path from clinical insight to market readiness. While the team brought deep technical and clinical expertise, they needed experienced operational leadership to drive commercialization.
Through the LifeX Connect Program, Netramind was matched with Justin Shaka, an experienced medical device founder with relevant domain expertise and strong alignment to the company’s stage and needs. This partnership introduced the executional focus and entrepreneurial leadership required to accelerate progress.
Result:
A strengthened leadership team, clearer commercialization strategy, and meaningful momentum toward investor readiness.
LifeX Connect Case Study: Advanced Respiratory Technologies (ART)
As ART prepared for its next phase of commercialization, the company joined the Spring 2026 LifeX Accelerator with a clear goal: strengthen investor readiness and sharpen its fundraising story ahead of its first institutional financing round. The program gave ART a structured environment to refine its strategy while continuing to advance both technical and commercial priorities.
Throughout the Accelerator, ART leveraged LifeX as a platform for coordinated execution. Through access to experienced operators, industry experts, investors, and targeted commercialization resources, the company gained opportunities to pressure-test assumptions, refine priorities, and strengthen key aspects of its growth strategy.
Result:
A meaningful shift in clarity and alignment led to a more focused market entry strategy, stronger clinical alignment, and a more structured investor approach.
Made Possible By Our Supporters & Partners
